Home › NDC Lookup › RxCUI directory › RxCUI 1232104

Zinc oxide 100 MG/ML Topical Spray — RxCUI 1232104

RxNorm drug concept · Semantic clinical drug
RxCUI 1232104 Semantic clinical drug · SCD ● Current RxNorm concept 2 FDA products 3 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI1232104
Official nameZinc oxide 100 MG/ML Topical Spray
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asZNO 100 MG/ML Topical Spray; zinc oxide 10 % Topical Spray
FDA products mapped2
Package NDCs mapped3
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

🕸️ Concept Web — How Zinc oxide 100 MG/ML Topical Spray Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Zinc oxide 100 MG/ML Topical Spray RxCUI 1232104

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Zinc oxide 11423
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Dr. Smith's Diaper Rash 1494199
  3. Dose forms 6

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Zinc oxide Topical Spray 377379
    • Zinc oxide Topical Product 1163041
    • Zinc oxide Topical Spray [Dr. Smith's Diaper Rash] 1494201
    • Dr. Smith's Diaper Rash Topical Product 1494202
    • Topical Spray 346165
    • Topical Product 1151122
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

    • Zinc oxide 100 MG/ML 343028
    • Zinc oxide 100 MG/ML Topical Spray [Dr. Smith's Diaper Rash] 1494203
    • Zinc oxide 100 MG/ML [Dr. Smith's Diaper Rash] 1494200

Showing up to 8 concepts per family — 11 of 11 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Zinc oxide 100 MG/ML SCDC · 343028
  • Zinc oxide Topical Spray SCDF · 377379
  • Zinc oxide Topical Product SCDG · 1163041

Brand-Name Concepts

  • Zinc oxide 100 MG/ML Topical Spray [Dr. Smith's Diaper Rash] SBD · 1494203
  • Zinc oxide 100 MG/ML [Dr. Smith's Diaper Rash] SBDC · 1494200
  • Zinc oxide Topical Spray [Dr. Smith's Diaper Rash] SBDF · 1494201
  • Dr. Smith's Diaper Rash Topical Product SBDG · 1494202
  • Dr. Smith's Diaper Rash BN · 1494199

📦 FDA Products & Package NDCs

2 products · 3 package NDCs
3 package NDCs map to RxCUI 1232104 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
51672-5318-03 1 BOTTLE, SPRAY in 1 CARTON (51672-5318-3) / 50 mL in 1 BOT... Bebe Bottoms TARO PHARMACEUTICALS U.S.A., INC. 2023-12-01
51672-5318-07 1 BOTTLE, SPRAY in 1 CARTON (51672-5318-7) / 100 mL in 1 BO... Bebe Bottoms TARO PHARMACEUTICALS U.S.A., INC. 2023-12-01
69366-0509-04 59 mL in 1 BOTTLE, SPRAY (69366-509-04) Sprayable Diaper Rash Cream The Honest Company, Inc. 2022-06-06
Observed labelers: TARO PHARMACEUTICALS U.S.A., INC. (2) · The Honest Company, Inc. (1) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.